Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 503

1.

Anxiety and distress during active surveillance for early prostate cancer.

van den Bergh RC, Essink-Bot ML, Roobol MJ, Wolters T, Schröder FH, Bangma CH, Steyerberg EW.

Cancer. 2009 Sep 1;115(17):3868-78. doi: 10.1002/cncr.24446.

2.

Do anxiety and distress increase during active surveillance for low risk prostate cancer?

van den Bergh RC, Essink-Bot ML, Roobol MJ, Schröder FH, Bangma CH, Steyerberg EW.

J Urol. 2010 May;183(5):1786-91. doi: 10.1016/j.juro.2009.12.099. Epub 2010 Mar 17.

PMID:
20299064
3.

Prostate cancer-specific anxiety in Dutch patients on active surveillance: validation of the memorial anxiety scale for prostate cancer.

van den Bergh RC, Korfage IJ, Borsboom GJ, Steyerberg EW, Essink-Bot ML.

Qual Life Res. 2009 Oct;18(8):1061-6. doi: 10.1007/s11136-009-9516-9. Epub 2009 Aug 9.

4.

A longitudinal study on the impact of active surveillance for prostate cancer on anxiety and distress levels.

Venderbos LD, van den Bergh RC, Roobol MJ, Schröder FH, Essink-Bot ML, Bangma CH, Steyerberg EW, Korfage IJ.

Psychooncology. 2015 Mar;24(3):348-54. doi: 10.1002/pon.3657. Epub 2014 Aug 20.

PMID:
25138075
5.

Prospective study of men's psychological and decision-related adjustment after treatment for localized prostate cancer.

Steginga SK, Occhipinti S, Gardiner RA, Yaxley J, Heathcote P.

Urology. 2004 Apr;63(4):751-6.

PMID:
15072894
6.

Prostate cancer active surveillance and health-related quality of life: results of the Finnish arm of the prospective trial.

Vasarainen H, Lokman U, Ruutu M, Taari K, Rannikko A.

BJU Int. 2012 Jun;109(11):1614-9. doi: 10.1111/j.1464-410X.2011.10677.x. Epub 2011 Nov 1.

7.

Perception of cancer and inconsistency in medical information are associated with decisional conflict: a pilot study of men with prostate cancer who undergo active surveillance.

Goh AC, Kowalkowski MA, Bailey DE Jr, Kazer MW, Knight SJ, Latini DM.

BJU Int. 2012 Jul;110(2 Pt 2):E50-6. doi: 10.1111/j.1464-410X.2011.10791.x. Epub 2011 Dec 7.

8.

Measuring the psychosocial impact of population-based prostate-specific antigen testing for prostate cancer in the UK.

Brindle LA, Oliver SE, Dedman D, Donovan JL, Neal DE, Hamdy FC, Lane JA, Peters TJ.

BJU Int. 2006 Oct;98(4):777-82.

9.

The psychological aftermath of prostate cancer treatment choices: a comparison of depression, anxiety and quality of life outcomes over the 12 months following diagnosis.

Couper JW, Love AW, Dunai JV, Duchesne GM, Bloch S, Costello AJ, Kissane DW.

Med J Aust. 2009 Apr 6;190(7 Suppl):S86-9.

PMID:
19351300
10.

Psychological distress in Japanese men with localized prostate cancer.

Namiki S, Saito S, Tochigi T, Numata I, Ioritani N, Arai Y.

Int J Urol. 2007 Oct;14(10):924-9.

11.

Health literacy and shared decision making for prostate cancer patients with low socioeconomic status.

Kim SP, Knight SJ, Tomori C, Colella KM, Schoor RA, Shih L, Kuzel TM, Nadler RB, Bennett CL.

Cancer Invest. 2001;19(7):684-91.

PMID:
11577809
12.

Short-term effects of population-based screening for prostate cancer on health-related quality of life.

Essink-Bot ML, de Koning HJ, Nijs HG, Kirkels WJ, van der Maas PJ, Schröder FH.

J Natl Cancer Inst. 1998 Jun 17;90(12):925-31.

PMID:
9637143
13.

The prevalence and predictors of psychological distress in patients with early localized prostate cancer.

Bisson JI, Chubb HL, Bennett S, Mason M, Jones D, Kynaston H.

BJU Int. 2002 Jul;90(1):56-61.

14.

Dimensions of quality of life expressed by men treated for metastatic prostate cancer.

Clark JA, Wray N, Brody B, Ashton C, Giesler B, Watkins H.

Soc Sci Med. 1997 Oct;45(8):1299-309.

PMID:
9381242
16.

The relationship between anxiety and time to treatment for patients with prostate cancer on surveillance.

Latini DM, Hart SL, Knight SJ, Cowan JE, Ross PL, Duchane J, Carroll PR; CaPSURE Investigators.

J Urol. 2007 Sep;178(3 Pt 1):826-31; discussion 831-2. Epub 2007 Jul 16.

PMID:
17632144
17.
18.

The memorial anxiety scale for prostate cancer: validation of a new scale to measure anxiety in men with with prostate cancer.

Roth AJ, Rosenfeld B, Kornblith AB, Gibson C, Scher HI, Curley-Smart T, Holland JC, Breitbart W.

Cancer. 2003 Jun 1;97(11):2910-8.

19.

Differences in health-related quality of life of prostate cancer patients based on stage of cancer.

Rosenfeld B, Roth AJ, Gandhi S, Penson D.

Psychooncology. 2004 Nov;13(11):800-7.

PMID:
15386638
20.

The measurement of psychological distress in men being investigated for the presence of prostate cancer.

Awsare NS, Green JS, Aldwinckle B, Hanbury DC, Boustead GB, McNicholas TA.

Prostate Cancer Prostatic Dis. 2008;11(4):384-9. doi: 10.1038/pcan.2008.21. Epub 2008 Apr 22.

PMID:
18427569

Supplemental Content

Support Center